Treatment Modality Eosinophilic lung diseases (ELD) are a varying group of conditions that are accompanied by increased eosinophils in the lung. Eosinophils are predominantly tissue-resident cell and specific leukocytes implicated in immune function for inflammatory reactions to allergic diseases or various infections. The cause of AEP is most commonly unknown.
Discuss one pathology associated with acute eosinophilic pneumonia and identify a treatment modality to relieve or minimize the signs/symptoms.
